New contact lens delivers glaucoma drug; Mass vaccination inhaler could be used in natural disasters; Pediatric leukemia drug delivered with less pain;

> A contact lens designed by researchers at Harvard Medical School, Boston Children's Hospital and MIT has a thin layer of latanaprost, which is the most common drug used to treat glaucoma and could be better at delivering the drug than eyedrops. Article

> Cambridge, U.K.-based Team Consulting designed a mass vaccination technology that administers vaccines via an inhaler. The low-cost Occoris inhaler could help vaccinate people in areas hit by natural disasters, according to a Business Weekly article.

> A pediatric leukemia chemotherapy drug long administered via painful intramuscular injection may now be safely administered via IV infusion due to a reformulation. Story

> Battelle and Zogenix ($ZGNX) have renewed an agreement to co-market Zogenix's drug delivery system designed for self-injection of biologic therapies. More

> Adocia signed an exclusive lisence agreement with the CNRS, the University Bordeaux I, the Institut Polytechnique de Bordeaux and Aquitaine Science Transfert, granting Adocia protection of its nanotech-based cancer drug delivery system. More